JP2024502954A5 - - Google Patents
Info
- Publication number
- JP2024502954A5 JP2024502954A5 JP2023539784A JP2023539784A JP2024502954A5 JP 2024502954 A5 JP2024502954 A5 JP 2024502954A5 JP 2023539784 A JP2023539784 A JP 2023539784A JP 2023539784 A JP2023539784 A JP 2023539784A JP 2024502954 A5 JP2024502954 A5 JP 2024502954A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- optionally substituted
- cells
- independently
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163139734P | 2021-01-20 | 2021-01-20 | |
| US63/139,734 | 2021-01-20 | ||
| PCT/US2022/012941 WO2022159463A1 (en) | 2021-01-20 | 2022-01-19 | Nanomaterials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502954A JP2024502954A (ja) | 2024-01-24 |
| JP2024502954A5 true JP2024502954A5 (enExample) | 2025-01-24 |
Family
ID=82549752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023539784A Pending JP2024502954A (ja) | 2021-01-20 | 2022-01-19 | ナノ材料 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12059477B2 (enExample) |
| EP (1) | EP4281050A4 (enExample) |
| JP (1) | JP2024502954A (enExample) |
| KR (1) | KR20230131863A (enExample) |
| CN (1) | CN116761888A (enExample) |
| AU (1) | AU2022210313A1 (enExample) |
| CA (1) | CA3203742A1 (enExample) |
| IL (1) | IL303846A (enExample) |
| MX (1) | MX2023008333A (enExample) |
| WO (1) | WO2022159463A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| JP2024503441A (ja) * | 2021-01-20 | 2024-01-25 | ビーム セラピューティクス インク． | イオン化可能な脂質を含むナノ材料 |
| CA3260437A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | NANOMATERIALS INCLUDING TRIOLS |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110977A (en) | 1990-02-14 | 1992-05-05 | Eastman Kodak Company | Ester-containing quaternary ammonium salts as adhesion improving toner charge agents |
| US20030083272A1 (en) | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| CA2721333C (en) | 2008-04-15 | 2020-12-01 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
| PE20181541A1 (es) | 2011-10-27 | 2018-09-26 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco |
| CN107879960B (zh) | 2013-03-08 | 2021-06-22 | 诺华股份有限公司 | 用于传递活性成分的脂质和脂质组合物 |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| EP3083556B1 (en) | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| ES2880103T3 (es) * | 2015-05-21 | 2021-11-23 | Ohio State Innovation Foundation | Derivados de benceno-1, 3, 5-tricarboxamida y usos de los mismos |
| JP6948313B6 (ja) | 2015-09-17 | 2022-01-14 | モデルナティエックス インコーポレイテッド | 治療剤の細胞内送達のための化合物および組成物 |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| CN120682290A (zh) | 2017-07-04 | 2025-09-23 | 尹图赛利有限公司 | 包含可裂解接头的化合物及其用途 |
| CA3081414A1 (en) | 2017-10-30 | 2019-05-09 | Georgia Tech Research Corporation | Multiplexed analysis of materials for tissue delivery |
| US11622942B2 (en) | 2017-11-14 | 2023-04-11 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof |
| US20220009878A1 (en) | 2018-10-02 | 2022-01-13 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| BR112021010853A2 (pt) * | 2018-12-05 | 2021-08-31 | Intellia Therapeutics, Inc. | Lipídios de amina modificados |
| CN119700703A (zh) | 2019-01-17 | 2025-03-28 | 佐治亚技术研究公司 | 含有氧化的胆固醇的药物递送系统 |
| JP7693552B2 (ja) | 2019-02-13 | 2025-06-17 | ビーム セラピューティクス インク． | アデノシンデアミナーゼ塩基エディターおよびそれを用いて標的配列中の核酸塩基を改変する方法 |
| CN114127044A (zh) | 2019-04-25 | 2022-03-01 | 英特利亚治疗股份有限公司 | 可电离的胺类脂质和脂质纳米颗粒 |
| JP2022536112A (ja) | 2019-06-05 | 2022-08-12 | ガイド セラピューティクス，インコーポレーテッド | 組織送達のための材料の分析 |
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| WO2021021636A1 (en) | 2019-07-29 | 2021-02-04 | Georgia Tech Research Corporation | Oligonucleotide antagonists for rna guided genome editing |
| KR20220113737A (ko) | 2019-12-06 | 2022-08-16 | 가이드 테라퓨틱스 엘엘씨 | 나노물질 |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| EP4262819A4 (en) | 2020-12-21 | 2024-12-04 | Beam Therapeutics Inc. | NANOMATERIALS WITH ESTER-BOUND ACETALS |
| EP4262818A4 (en) | 2020-12-21 | 2025-03-26 | Beam Therapeutics Inc. | NANOMATERIALS WITH CARBONATES |
| JP2024503976A (ja) | 2020-12-21 | 2024-01-30 | ビーム セラピューティクス インク． | アセタールを含むナノ材料 |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| JP2024503441A (ja) | 2021-01-20 | 2024-01-25 | ビーム セラピューティクス インク． | イオン化可能な脂質を含むナノ材料 |
| CA3203784A1 (en) | 2021-01-20 | 2022-07-28 | Beam Therapeutics Inc. | Ionizable lipids for nanomaterials |
| EP4452925A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Nanomaterial comprising diamines |
| WO2023121970A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine and ester lipids and lipid nanoparticles |
| CA3241488A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine lipids and lipid nanoparticles |
| JP2025500824A (ja) | 2021-12-20 | 2025-01-15 | ビーム セラピューティクス インク． | 四価脂質化合物を含むナノ材料 |
| EP4452942A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
-
2022
- 2022-01-19 CN CN202280009717.5A patent/CN116761888A/zh active Pending
- 2022-01-19 KR KR1020237024632A patent/KR20230131863A/ko active Pending
- 2022-01-19 AU AU2022210313A patent/AU2022210313A1/en active Pending
- 2022-01-19 CA CA3203742A patent/CA3203742A1/en active Pending
- 2022-01-19 WO PCT/US2022/012941 patent/WO2022159463A1/en not_active Ceased
- 2022-01-19 IL IL303846A patent/IL303846A/en unknown
- 2022-01-19 EP EP22743085.7A patent/EP4281050A4/en active Pending
- 2022-01-19 US US17/579,115 patent/US12059477B2/en active Active
- 2022-01-19 JP JP2023539784A patent/JP2024502954A/ja active Pending
- 2022-01-19 MX MX2023008333A patent/MX2023008333A/es unknown
-
2024
- 2024-06-24 US US18/751,931 patent/US20250041441A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502954A5 (enExample) | ||
| JP2024505449A5 (enExample) | ||
| JP2024502948A5 (enExample) | ||
| JP2024503441A5 (enExample) | ||
| JP2025500824A5 (enExample) | ||
| JP2025501731A5 (enExample) | ||
| JP5813778B2 (ja) | トール様受容体に基づく免疫反応を調節するための免疫調節オリゴヌクレオチド（ｉｒｏ）化合物 | |
| EP2996472B1 (en) | Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling | |
| JP2024505327A (ja) | 炭酸塩を含むナノ材料 | |
| JP2018537528A (ja) | Ｎｌｒｐ３遺伝子発現を阻害するための組成物およびその使用 | |
| CN112805294A (zh) | 用于核酸递送的叔氨基脂化的阳离子肽 | |
| JP2025505971A (ja) | 脂質ナノ粒子用のイオン化できるカチオン性脂質 | |
| JP2019504002A5 (enExample) | ||
| AU2009302468A1 (en) | Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto | |
| JP2009515823A (ja) | トール様受容体に基づく免疫反応を調整する免疫調節ヌクレオチド（ｉｒｏ）化合物 | |
| CN117440834A (zh) | 核糖核酸的体内递送用组合物及其制备方法 | |
| CN118421594A (zh) | 包含突变kras序列和脂质的化合物及其用途 | |
| JP2024535004A (ja) | イオン化可能な脂質その調製および遺伝子送達における使用 | |
| JP2024503976A5 (enExample) | ||
| BR112015016420B1 (pt) | Composto de oligonucleotídeo imunorregulatório, composição farmacêutica e uso do composto iro ou da composição farmacêutica | |
| JP2018150239A (ja) | β２ＧＰＩ遺伝子発現抑制ＲＮＡｉ医薬組成物 | |
| WO2024183821A1 (zh) | 可离子化脂质分子及其制备方法和应用 | |
| TWI876778B (zh) | 用於傳遞核酸的基於環烷的脂質化合物以及包括其之脂質奈米粒子 | |
| WO2018084168A1 (ja) | 皮膚線維症処置剤 | |
| US11802139B2 (en) | Pharmaceutical composition and the use thereof in the treatment of autoimmune diseases |